Combating Metabolic Syndrome through Non-Pharmacological Strategies: A Literature Review

Combating Metabolic Syndrome

Authors

  • Zubia Aziz Department of Biochemistry, Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Huma Shareef Department of Pharmcognosy, Jinnah Sindh Medical University, Karachi, Pakistan
  • Eesha Afridi Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Musab Kashif Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Makashfa Hussain Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Maria Waseem Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Talha Shahid Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Muhammad Arsalan Khan Liaquat College of Medicine and Dentistry, Karachi, Pakistan
  • Sidra Tul Muntaha Department of Pediatrics, Darul-Sehat Hospital, Karachi, Pakistan
  • Hallar Hameed Silro Karachi Medical and Dental College, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i11.1145

Keywords:

Metabolic Syndrome, Non-Pharmacological Management, Diet, Obesity

Abstract

Metabolic syndrome (MetS) represents a constellation of interlinked metabolic abnormalities, encompassing hypertension (HTN), insulin resistance diabetes, obesity, and atherogenic dyslipidemia. It is observed that people suffering from these symptoms of metabolic syndrome are twice as likely to develop cardiovascular diseases (CVDS) and five times more likely to develop Type 2 Diabetes Mellitus (T2DM) during their lifetime. The alarming increase in the incidence of MetS, in population worldwide, has made it an epidemic. In today’s world people are more susceptible to MetS due to their sedentary lifestyle, bad eating habits, and various forms of stress. Knowing the socioeconomic burden of disease of MetS on global health throughout the years has brought attention towards its management and therapeutic approach and rightly so, this has also created the need for new, innovative, and non-traditional methods of managing MetS, as the current available treatments of MetS have limited efficacy. In this review, we highlight the prevalence, definition and also summarize the latest non-traditional therapies of MetS worldwide.

References

Reaven GM. Role of insulin resistance in human disease. Nutrition. 1997; 1(13): 65. doi: 10.1016/s0899-9007(96)00380-2 . DOI: https://doi.org/10.1016/S0899-9007(96)00380-2

Gupta A and Gupta V. Metabolic syndrome: what are the risks for humans? Bioscience Trends. 2010 Oct; 4(5): 204-12.

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009 Oct; 120(16): 1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192644

Samson SL and Garber AJ. Metabolic syndrome. Endocrinology and Metabolism Clinics. 2014 Mar; 43(1): 1-23. doi: 10.1016/j.ecl.2013.09.009. DOI: https://doi.org/10.1016/j.ecl.2013.09.009

Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M, Estruch R, Casas R. Dietary strategies for metabolic syndrome: a comprehensive review. Nutrients. 2020 Sep; 12(10): 2983. doi: 10.3390/nu12102983. DOI: https://doi.org/10.3390/nu12102983

Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease. 2017 Aug; 11(8): 215-25. doi: 10.1177/1753944717711379. DOI: https://doi.org/10.1177/1753944717711379

Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis. The Lancet Child & Adolescent Health. 2022 Mar; 6(3): 158-70. doi: 10.1016/s2352-4642(21)00374-6. DOI: https://doi.org/10.1016/S2352-4642(21)00374-6

McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clinics in Dermatology. 2018 Jan; 36(1): 14-20. doi: 10.1016/j.clindermatol.2017.09.004. DOI: https://doi.org/10.1016/j.clindermatol.2017.09.004

Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: Updates on pathophysiology and management in 2021. International Journal of Molecular Sciences. 2022 Jan; 23(2): 786. doi: 10.3390/ijms23020786. DOI: https://doi.org/10.3390/ijms23020786

Bell PG, Walshe IH, Davison GW, Stevenson E, Howatson G. Montmorency cherries reduce the oxidative stress and inflammatory responses to repeated days high-intensity stochastic cycling. Nutrients. 2014 Feb; 6(2): 829-43. doi: 10.3390/nu6020829. DOI: https://doi.org/10.3390/nu6020829

Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC: Cardiovascular Imaging. 2014 Dec; 7(12): 1221-35. doi: 10.1016/j.jcmg.2014.07.017. DOI: https://doi.org/10.1016/j.jcmg.2014.07.017

Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Medicine. 2011 Dec; 9: 1-3. doi: 10.1186/1741-7015-9-48. DOI: https://doi.org/10.1186/1741-7015-9-48

Saklayen MG. The global epidemic of the metabolic syndrome. Current Hypertension Reports. 2018 Feb; 20(2): 1-8. doi: 10.1007/s11906-018-0812-z. DOI: https://doi.org/10.1007/s11906-018-0812-z

D’Alessandro A and De Pergola G. Mediterranean diet pyramid: a proposal for Italian people. Nutrients. 2014 Oct; 6(10): 4302-16. doi: 10.3390/nu6104302. DOI: https://doi.org/10.3390/nu6104302

Salas-Salvadó J, Bulló M, Babio N, Martínez-González MÁ, Ibarrola-Jurado N, Basora J, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes care. 2011 Jan; 34(1): 14-9. doi: 10.2337/dc10-1288. DOI: https://doi.org/10.2337/dc10-1288

Salas-Salvadó J, Bulló M, Estruch R, Ros E, Covas MI, Ibarrola-Jurado N, et al. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Annals of Internal Medicine. 2014 Jan; 160(1): 1-10. doi: 10.7326/m13-1725. DOI: https://doi.org/10.7326/M13-1725

Mazzocchi A, Leone L, Agostoni C, Pali-Schöll I. The secrets of the Mediterranean diet. Does [only] olive oil matter? Nutrients. 2019 Dec; 11(12): 2941. doi: 10.3390/nu11122941. DOI: https://doi.org/10.3390/nu11122941

Dayi T and Ozgoren M. Effects of the Mediterranean diet on the components of metabolic syndrome. Journal of Preventive Medicine and Hygiene. 2022 Jun; 63(2 Suppl 3): E56. doi: 10.15167/2421-4248/jpmh2022.63.2s3.2747.

Marrone G, Guerriero C, Palazzetti D, Lido P, Marolla A, Di Daniele F, et al. Vegan diet health benefits in metabolic syndrome. Nutrients. 2021 Mar; 13(3): 817. doi: 10.3390/nu13030817. DOI: https://doi.org/10.3390/nu13030817

Gomez-Delgado F, Katsiki N, Lopez-Miranda J, Perez-Martinez P. Dietary habits, lipoprotein metabolism and cardiovascular disease: From individual foods to dietary patterns. Critical Reviews in Food Science and Nutrition. 2021 May; 61(10): 1651-69. doi: 10.1080/10408398.2020.1764487. DOI: https://doi.org/10.1080/10408398.2020.1764487

Ali O. Lifestyles for the Optimum Quality of Life. Asian Journal of Medicine and Health Science. 2023 Jun; 6(1): 23.

Wakolbinger-Habel R, Reinweber M, König J, Pokan R, König D, Pietschmann P, et al. Self-reported Resistance Training Is Associated With Better HR-pQCT–derived Bone Microarchitecture in Vegan People. The Journal of Clinical Endocrinology & Metabolism. 2022 Sep; 107(10): 2900-11. doi: 10.1210/clinem/dgac445. DOI: https://doi.org/10.1210/clinem/dgac445

Bakaloudi DR, Halloran A, Rippin HL, Oikonomidou AC, Dardavesis TI, Williams J, et al. Intake and adequacy of the vegan diet. A systematic review of the evidence. Clinical Nutrition. 2021 May; 40(5): 3503-21. doi: 10.1016/j.clnu.2020.11.035. DOI: https://doi.org/10.1016/j.clnu.2020.11.035

Rogerson D. Vegan diets: practical advice for athletes and exercisers. Journal of the International Society of Sports Nutrition. 2017 Sep; 14(1): 36. doi: 10.1186/s12970-017-0192-9. DOI: https://doi.org/10.1186/s12970-017-0192-9

Vasim I, Majeed CN, DeBoer MD. Intermittent fasting and metabolic health. Nutrients. 2022 Jan; 14(3): 631. doi: 10.3390/nu14030631. DOI: https://doi.org/10.3390/nu14030631

Wang X, Li Q, Liu Y, Jiang H, Chen W. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: a systematic review and meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice. 2021 Sep; 179: 109003. doi: 10.1016/j.diabres.2021.109003. DOI: https://doi.org/10.1016/j.diabres.2021.109003

Teong XT, Liu K, Vincent AD, Bensalem J, Liu B, Hattersley KJ, et al. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial. Nature Medicine. 2023 Apr; 29: 963-72. doi: 10.1038/s41591-023-02287-7. DOI: https://doi.org/10.1038/s41591-023-02287-7

Antoni R, Johnston KL, Collins AL, Robertson MD. Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants. British Journal of Nutrition. 2018 Mar; 119(5): 507-16. doi: 10.1017/s0007114517003890. DOI: https://doi.org/10.1017/S0007114517003890

Corley BT, Carroll RW, Hall RM, Weatherall M, Parry‐Strong A, Krebs J. Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabetic Medicine. 2018 May; 35(5): 588-94. doi: 10.1111/dme.13595. DOI: https://doi.org/10.1111/dme.13595

Joaquim L, Faria A, Loureiro H, Matafome P. Benefits, mechanisms, and risks of intermittent fasting in metabolic syndrome and type 2 diabetes. Journal of Physiology and Biochemistry. 2022 May; 78(2): 295-305. doi: 10.1007/s13105-021-00839-4. DOI: https://doi.org/10.1007/s13105-021-00839-4

Nowosad K and Sujka M. Effect of various types of intermittent fasting (IF) on weight loss and improvement of diabetic parameters in human. Current Nutrition Reports. 2021 Jun; 10: 146-54. doi: 10.1007/s13668-021-00353-5. DOI: https://doi.org/10.1007/s13668-021-00353-5

Guo Y, Luo S, Ye Y, Yin S, Fan J, Xia M. Intermittent fasting improves cardiometabolic risk factors and alters gut microbiota in metabolic syndrome patients. The Journal of Clinical Endocrinology & Metabolism. 2021 Jan; 106(1): 64-79. doi: 10.1210/clinem/dgaa644. DOI: https://doi.org/10.1210/clinem/dgaa644

Moran-Lev H, Cohen S, Zelber-Sagi S, Mazkeret Mayer E, Anafy A, Yerushalmy-Feler A, et al. Effect of coffee and tea consumption on adolescent weight control: an interventional pilot study. Childhood Obesity. 2023 Mar; 19(2): 121-9. doi: 10.1089/chi.2022.0032. DOI: https://doi.org/10.1089/chi.2022.0032

Aziz MA, Millat MS, Akter T, Hossain MS, Islam MM, Mohsin S, et al. A comprehensive review on clinically proven medicinal plants in the treatment of overweight and obesity, with mechanistic insights. Heliyon. 2023 Feb; 9(2): e13493. doi: 10.1016/j.heliyon.2023.e13493. DOI: https://doi.org/10.1016/j.heliyon.2023.e13493

Sirotkin AV and Kolesarova A. The anti-obesity and health-promoting effects of tea and coffee. Physiological Research. 2021 Apr; 70(2): 161. doi: 10.33549/physiolres.934674. DOI: https://doi.org/10.33549/physiolres.934674

Unno K, Furushima D, Hamamoto S, Iguchi K, Yamada H, Morita A, et al. Stress-reducing function of matcha green tea in animal experiments and clinical trials. Nutrients. 2018 Oct; 10(10): 1468. doi: 10.3390/nu10101468. DOI: https://doi.org/10.3390/nu10101468

Yang CS, Wang H, Sheridan ZP. Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea. Journal of Food and Drug Analysis. 2018 Jan; 26(1): 1-3. doi: 10.1016/j.jfda.2017.10.010. DOI: https://doi.org/10.1016/j.jfda.2017.10.010

Yang CS, Zhang J, Zhang L, Huang J, Wang Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Molecular Nutrition & Food Research. 2016 Jan; 60(1): 160-74. doi: 10.1002/mnfr.201500428. DOI: https://doi.org/10.1002/mnfr.201500428

Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. British Journal of Nutrition. 2014 Apr; 111(7): 1263-71. doi: 10.1017/s0007114513003784. DOI: https://doi.org/10.1017/S0007114513003784

Li Y, Wang C, Huai Q, Guo F, Liu L, Feng R, et al. Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: a meta‐analysis of ten randomized controlled trials. Diabetes/Metabolism Research and Reviews. 2016 Jan; 32(1): 2-10. doi: 10.1002/dmrr.2641. DOI: https://doi.org/10.1002/dmrr.2641

Islam MT, Tabrez S, Jabir NR, Ali M, Kamal MA, da Silva Araujo L, et al. An insight into the therapeutic potential of major coffee components. Current Drug Metabolism. 2018 May; 19(6): 544-56. doi: 10.2174/1389200219666180302154551. DOI: https://doi.org/10.2174/1389200219666180302154551

Sarriá B, Martínez-López S, Sierra-Cinos JL, García-Diz L, Mateos R, Bravo-Clemente L. Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome. European Journal of Nutrition. 2018 Feb; 57: 269-78. doi: 10.1007/s00394-016-1316-8. DOI: https://doi.org/10.1007/s00394-016-1316-8

Khiali S, Agabalazadeh A, Sahrai H, Bannazadeh Baghi H, Rahbari Banaeian G, Entezari-Maleki T. Effect of caffeine consumption on cardiovascular disease: an updated review. Pharmaceutical Medicine. 2023 Mar 30: 1-3. doi: 10.1007/s40290-023-00466-y. DOI: https://doi.org/10.1007/s40290-023-00466-y

Bhatti SK, O’Keefe JH, Lavie CJ. Coffee and tea: perks for health and longevity? Current Opinion in Clinical Nutrition & Metabolic Care. 2013 Nov; 16(6): 688-97. doi: 10.1097/mco.0b013e328365b9a0. DOI: https://doi.org/10.1097/MCO.0b013e328365b9a0

Ricci E, Viganò P, Cipriani S, Somigliana E, Chiaffarino F, Bulfoni A, et al. Coffee and caffeine intake and male infertility: a systematic review. Nutrition Journal. 2017 Dec; 16: 1-4. doi: 10.1186/s12937-017-0257-2. DOI: https://doi.org/10.1186/s12937-017-0257-2

Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: a systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2019 May; 33(5): 1289-301. doi: 10.1002/ptr.6323. DOI: https://doi.org/10.1002/ptr.6323

Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Curcumin in metabolic health and disease. Nutrients. 2021; 13: 4440. doi: 10.3390/nu13124440. DOI: https://doi.org/10.3390/nu13124440

Hosseini H, Ghavidel F, Panahi G, Majeed M, Sahebkar A. A systematic review and meta‐analysis of randomized controlled trials investigating the effect of the curcumin and piperine combination on lipid profile in patients with metabolic syndrome and related disorders. Phytotherapy Research. 2023 Mar; 37(3): 1212-24. doi: 10.1002/ptr.7730. DOI: https://doi.org/10.1002/ptr.7730

Reeta V and Kalia S. Turmeric: A review of its’ effects on human health. Journal of Medicinal Plants Studies. 2022 May; 10(4): 61-3.

Cianfruglia L, Minnelli C, Laudadio E, Scirè A, Armeni T. Side effects of curcumin: Epigenetic and antiproliferative implications for normal dermal fibroblast and breast cancer cells. Antioxidants. 2019 Sep; 8(9): 382. doi: 10.3390/antiox8090382. DOI: https://doi.org/10.3390/antiox8090382

Oka Y, Takahashi K, Ohta T. The effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel. Biochemistry and Biophysics Reports. 2022 Jul; 30: 101243. doi: 10.1016/j.bbrep.2022.101243. DOI: https://doi.org/10.1016/j.bbrep.2022.101243

Panchal SK, Bliss E, Brown L. Capsaicin in metabolic syndrome. Nutrients. 2018 May; 10(5): 630. doi: 10.3390/nu10050630 DOI: https://doi.org/10.3390/nu10050630

Jiang Z, Qu H, Lin G, Shi D, Chen K, Gao Z. Lipid-Lowering Efficacy of the Capsaicin in Patients With Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Nutrition. 2022 Mar; 9; 812294. doi: 10.3389/fnut.2022.812294. DOI: https://doi.org/10.3389/fnut.2022.812294

Elmas C and Gezer C. Capsaicin and Its Effects on Body Weight. Journal of the American Nutrition Association. 2022 Nov; 41(8): 831-9. doi: 10.1080/07315724.2021.1962771. DOI: https://doi.org/10.1080/07315724.2021.1962771

Szallasi A. Dietary Capsaicin: A Spicy Way to Improve Cardio-Metabolic Health? Biomolecules. 2022 Nov; 12(12): 1783. doi: 10.3390/biom12121783. DOI: https://doi.org/10.3390/biom12121783

Ramos-Romero S, Torrella JR, Pagès T, Viscor G, Torres JL. Edible microalgae and their bioactive compounds in the prevention and treatment of metabolic alterations. Nutrients. 2021 Feb; 13(2): 563. doi: 10.3390/nu13020563. DOI: https://doi.org/10.3390/nu13020563

Mayer C, Richard L, Côme M, Ulmann L, Nazih H, Chénais B, et al. The marine microalga, Tisochrysis lutea, protects against metabolic disorders associated with metabolic syndrome and obesity. Nutrients. 2021 Jan; 13(2): 430. doi: 10.3390/nu13020430. DOI: https://doi.org/10.3390/nu13020430

Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey Jr G, Goh YJ, et al. Prebiotics: why definitions matter. Current Opinion in Biotechnology. 2016 Feb; 37: 1-7. doi: 10.1016/j.copbio.2015.09.001. DOI: https://doi.org/10.1016/j.copbio.2015.09.001

Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, et al. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review. Nutrients. 2021 Sep; 13(9): 3211. doi: 10.3390/nu13093211. DOI: https://doi.org/10.3390/nu13093211

Silva-Cutini MA, Almeida SA, Nascimento AM, Abreu GR, Bissoli NS, Lenz D, et al. Long-term treatment with kefir probiotics ameliorates cardiac function in spontaneously hypertensive rats. The Journal of Nutritional Biochemistry. 2019 Apr; 66: 79-85. doi: 10.1016/j.jnutbio.2019.01.006. DOI: https://doi.org/10.1016/j.jnutbio.2019.01.006

Kobyliak N, Falalyeyeva T, Bodnar P, Beregova T. Probiotics supplemented with omega-3 fatty acids are more effective for hepatic steatosis reduction in an animal model of obesity. Probiotics and Antimicrobial Proteins. 2017 Jun; 9: 123-30. doi: 10.1007/s12602-016-9230-1. DOI: https://doi.org/10.1007/s12602-016-9230-1

Kobyliak N, Falalyeyeva T, Boyko N, Tsyryuk O, Beregova T, Ostapchenko L. Probiotics and nutraceuticals as a new frontier in obesity prevention and management. Diabetes Research and Clinical Practice. 2018 Jul; 141: 190-9. doi: 10.1016/j.diabres.2018.05.005. DOI: https://doi.org/10.1016/j.diabres.2018.05.005

Li Y, Liu M, Liu H, Wei X, Su X, Li M, et al. Oral supplements of combined Bacillus licheniformis Zhengchangsheng® and xylooligosaccharides improve high-fat diet-induced obesity and modulate the gut microbiota in rats. BioMed Research International. 2020 May; 2020: 9067821. doi: 10.1155/2020/9067821. DOI: https://doi.org/10.1155/2020/9067821

Liu Z, Li L, Ma S, Ye J, Zhang H, Li Y, et al. High-dietary fiber intake alleviates antenatal obesity-induced postpartum depression: Roles of gut microbiota and microbial metabolite short-chain fatty acid involved. Journal of Agricultural and Food Chemistry. 2020 Nov; 68(47): 13697-710. doi: 10.1021/acs.jafc.0c04290. DOI: https://doi.org/10.1021/acs.jafc.0c04290

Green M, Arora K, Prakash S. Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome. International Journal of Molecular Sciences. 2020 Apr; 21(8): 2890. doi: 10.3390/ijms21082890. DOI: https://doi.org/10.3390/ijms21082890

Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? The American Journal of Clinical Nutrition. 2006 Jun; 83(6): 1256-64. doi: 10.1093/ajcn/83.6.1256. DOI: https://doi.org/10.1093/ajcn/83.6.1256

Deichmann R, Lavie C, Andrews S. Coenzyme q10 and statin-induced mitochondrial dysfunction. Ochsner Journal. 2010 Mar; 10(1): 16-21.

Ayer A, Macdonald P, Stocker R. CoQ10 function and role in heart failure and ischemic heart disease. Annual Review of Nutrition. 2015 Jul; 35: 175-213. doi: 10.1146/annurev-nutr-071714-034258. DOI: https://doi.org/10.1146/annurev-nutr-071714-034258

Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2004 Jan; 1660(1-2): 171-99. doi: 10.1016/j.bbamem.2003.11.012. DOI: https://doi.org/10.1016/j.bbamem.2003.11.012

Digiesi V, Cantini F, Oradei A, Bisi G, Guarino GC, Brocchi A, et al. Coenzyme Q10 in essential hypertension. Molecular Aspects of Medicine. 1994 Jan; 15: s257-63. doi: 10.1016/0098-2997(94)90036-1. DOI: https://doi.org/10.1016/0098-2997(94)90036-1

Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circulation Research. 1989 Jul; 65(1): 1-21. doi: 10.1161/01.res.65.1.1. DOI: https://doi.org/10.1161/01.RES.65.1.1

Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. Southern Medical Journal. 2001 Nov; 94(11): 1112-8. doi: 10.1097/00007611-200111000-00015. DOI: https://doi.org/10.1097/00007611-200111000-00015

Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Medicina Clínica (English Edition). 2018 May; 150(10): 398-402. doi: 10.1016/j.medcli.2017.11.030. DOI: https://doi.org/10.1016/j.medcle.2018.03.001

Niazi M, Galehdar N, Jamshidi M, Mohammadi R, Moayyedkazemi A. A review of the role of statins in heart failure treatment. Current Clinical Pharmacology. 2020 Apr; 15(1): 30-7. doi: 10.2174/1574884714666190802125627. DOI: https://doi.org/10.2174/1574884714666190802125627

Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacology & therapeutics. 2009 Dec; 124(3): 259-68. doi: 10.1016/j.pharmthera.2009.07.003. DOI: https://doi.org/10.1016/j.pharmthera.2009.07.003

Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in cardiovascular and metabolic diseases: current state of the problem. Current Cardiology Reviews. 2018 Aug; 14(3): 164-74. doi: 10.2174/1573403X14666180416115428. DOI: https://doi.org/10.2174/1573403X14666180416115428

Downloads

Published

2023-11-30
CITATION
DOI: 10.54393/pjhs.v4i11.1145
Published: 2023-11-30

How to Cite

Aziz, Z., Shareef, H., Afridi, E., Kashif, M., Hussain, M., Waseem, M., Shahid, T., Khan, M. A., Muntaha, S. T., & Hameed Silro, H. (2023). Combating Metabolic Syndrome through Non-Pharmacological Strategies: A Literature Review: Combating Metabolic Syndrome. Pakistan Journal of Health Sciences, 4(11), 20–28. https://doi.org/10.54393/pjhs.v4i11.1145

Issue

Section

Review Article

Plaudit